CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 154 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02651922
NCT02651922N/ACompleted
CompareCT.gov

Treatment of Patients Suffering From Nervous Restlessness With PASCOFLAIR®

Pascoe Pharmazeutische Praeparate GmbH·observational·Posted Jan 11, 2016·Updated Jul 30, 2024

In Brief

An observational study for Nervous Restlessness. Completed, enrolled 154 participants.

Detailed Summary

The study was carried out as a prospective, non-interventional study with the intention of subsequent process cost analyses (PCA) and also considers quality of life, drug misuse, dependence, adverse events and therapy satisfaction.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNervous Restlessness
Countries--
CollaboratorsInstitut für Empirische Gesundheitsökonomie, Prof. Dr. Dr.med. Reinhard Rychlik,Am Ziegelfeld 28,51399 Burscheid,Germany

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJan 11, 2016
Enrollment StartSep 1, 2014
Primary CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 10.5 years ago